期刊文献+

应激性高糖血症与胰岛素抵抗的相关因素研究 被引量:41

Study of relationship between stress hyperglycemia and insulin-resistance related factors
下载PDF
导出
摘要 目的探讨危重病应激状态与高糖血症相关的发病环节及致病因素。方法采用放射免疫分析或双抗体夹心酶联免疫吸附法测定47例应激性高糖血症(SHG)危重患者和15名正常人的血糖(BG)、胰岛素(INS)、C-肽(C-P)、胰高血糖素(Gluc)、生长激素释放抑制因子(SS)、皮质醇(Cor)、肿瘤坏死因子-α(TNF-α)、人可溶性TNF受体(sTNFR)和sTNFR,并计算胰岛素敏感指数(ISI)。结果147例SHG患者中存活36例,死亡11例;入重症监护室(ICU)24h内的急性生理学与慢性健康状况评分系统(A-PACHE)为(13.89±6.29)分,住ICU时间为(5.5±6.3)d,机械通气(MV)时间为(51.49±66.01)h。2SHG组的各项检测结果均明显高于正常对照组,除SS外,余各指标差异均有显著性(P<0.05或P<0.01)。3随着BG增高,反映胰腺β细胞功能的C-P浓度增高,ISI越差。4对不同APACHE评分分组比较显示,BG并不随病情危重程度的增加而升高,但MV时间、Cor、Gluc、SS、TNF-α、sTNFR和sTNFR均随病情的危重程度而增加,差异均有显著性。5SHG对MV时间的影响差异有显著性(F=10.438,P<0.01),而对年龄、预后、住ICU时间的影响差异均无显著性。6应激状态下影响BG升高的主要相关因素为:INS(r=0.674,P<0.01),C-P(r=0.552,P<0.01),ISI(r=-0.787,P<0.01),APACHE(r=0.267,P<0.05),sTNFR(r=0.465,P<0.01)。结论SHG的主要发病环节是胰岛素抵抗。受体前急性应激激素与SHG的调节关系不明确;sTNFR对SHG有介导作用,而TNF-α、sTNFR过度释放与SHG病情程度有关。BG水平与MV时间有关,与年龄、预后和住ICU时间无关。探讨治疗和预防SHG策略的重点应放在组织对BG的利用障碍方面,提高和增强组织对INS的敏感性。 Objective To observe related factors in the stress hyperglycemia (SHG) of critical illness and to investigate possible pathogenesis of insulin-resistance (IR). Methods Blood glucose (BG), insulin (INS), C - peptide (C - P), cortisol (Cor), somatostatin (SS), glucagon (Gluc), tumor necrosis factor - α (TNF - α), soluble tumor necrosis factor receptor Ⅰ (sTNFR Ⅰ ) and sTNFR Ⅱ were determined respectively by radioimmunoassay (RIA) or enzyme linked immunoadsorbent assay (ELISA) in 47 SHG patients with critical illness and 15 healthy volunteers serving as normal controls. Their insulin sensitivity index (ISI) was calculated. Results ①Eleven of 47 patients died, while 36 cases survived. Mean acute pathology and chronic health evaluation Ⅱ (APACHE Ⅱ ) was (13.89±6.29) scores within 24 hours after admission to intensive care unit (ICU), mean days of stay in ICU was (5.5±6.3) days, and mean duration of mechanical ventilation (MV) was (51.49 ± 66.01) hours. ②The concentrations of INS, ISI, C - P, Cor, Gluc, TNF - α, sTNFR Ⅰ and sTNFR Ⅱ in 47 SHG patients with critical illness were significantly higher than those in normal controls, except for SS, the differences among groups were significant (P〈0.05 or P〈0.01). ③The results of analysis of severity of SHG showed that the more severe SHG was, the higher C -P and INS were, and the less prominent ISI was. ④Analysis of scores of APACHE Ⅱ in 47 cases of SHG showed that BG was not increased, but duration of MV, Cor, Gluc, SS, TNF -α, sTNFR Ⅰ and sTNFR Ⅱ were significantly increased with higher scores of APACHE Ⅱ. The ⑤effect of SHG was significant on MV (F=10.438, P〈0.01), but not significant for outcome and days of stay in ICU. ⑥The main correlative factors of BG were respectively concentrations of INS (r=0. 674, P〈0. 01), C -P (r=0. 552, P〈0.01), ISI (r=-0.787, P〈0.01), APACHE Ⅱ (r=0.267, P〈0.05) and sTNFR Ⅰ (r=0.465, P〈0.01). Conclusion These results show that main reason of SHG in critical illness is IR. There is no strong significant correlation between acute stress hormones and the level of SHG. sTNFR Ⅰ has an influence on SHG. However, the over release of TNF - α and sTNFR Ⅱ could be the results of seriousness of the critical illness. There is closely correlation between BG and MV, but not with the age, outcome and days of stay in ICU. The strategy of control and therapy of SHG should be alleviation of stress and improve the utilization of BG in the tissue, and increase sensitivity of INS in the tissue.
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2006年第12期751-754,共4页 Chinese Critical Care Medicine
基金 宁夏回族自治区自然科学基金资助项目(A4014)
关键词 应激 血糖 胰岛素 皮质醇 胰高血糖素 肿瘤坏死因子-Α stress blood glucose, insulin cortisol glucagon tumor necrosis factor -
  • 相关文献

参考文献7

  • 1Scheen A J.Clinical study of the month,toxicity of hyperglycemia in intensive care and beneficial effects of optimized insulin therapy[J].Rev Med Liege,2001,56:859-861.
  • 2Chernow B,Alexander H R,Smallridge R C,et al.Hormonal responses to graded surgical stress[J].Arch Intern Med,1987,147:1273-1278.
  • 3Dahn M S,Lange M P,Mitchell R A,et al.Insulin production following injury and sepsis[J].J Trauma,1987,27:1031-1038.
  • 4李军,史忠,粟永萍.手术创伤后胰岛素抵抗的受体后机制[J].创伤外科杂志,2002,4(5):313-316. 被引量:19
  • 5Fisher C J,Agosti J M,Opal S M,et al.The soluble TNF receptor sepsis study group.Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein[J].N Engl J Med,1996,334:1697-1702.
  • 6Christiansen C,Toft P,Jorgensen H S,et al.Hyperglycemia and mortality in critically ill patients:a prospective study[J].Intensive Care Med,2004,30:1685-1688.
  • 7Krinsley J S.Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients[J].Mayo Clin Proc,2003,78:1471-1478.

二级参考文献22

  • 1[1]Thorell A, Nygren J, Hirshman MF, et al. Surgery-induced insulin resistance in human patients:relation to glucose transport and utilization[J]. Am J Physiol,1999,276(4pt1):E754-761.
  • 2[2]Anai M, Funaki M, Ogihara T, et al. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats[J].Diabetes,1998,47(1):13-23.
  • 3[3]Kanety H,Feinstein R,Papa MZ,et al. Tumor necrosis factor alpha-insuced phosphorlation of insulin receptor substrate-1(IRS-1):possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1[J]. J Biol Chem,1995,270(40):23780-23784.
  • 4[4]Ikezu T,Okamoto T,Yonezawa K,et al. Analysis of thermal injury-induced insulin resistance in rodents:implication of postreceptor mechanisms[J].J Biol Chem,1997,272(40):25289-25295.
  • 5[5]Folli F,Saad MJ,Backer JM,et al. Regulation of phosphatidyliositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus[J]. J Clin Invest,1993,92(4):1787-1794.
  • 6[6]Strommer L,Permert J,Arnelo U,et al. Skeletal muscle insulin resistance after trauma:insulin signaling and glucose transport[J].Am J Physiol,1998,275(2pt1):E351-358.
  • 7[7]Egawa K,Nakashima N,Sharma PM,et al. Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes[J].Endocrinology,2000,141(6):1930-1935.
  • 8[8]Itani SI,Zhou Q,Pories WJ,et al. Involvement of protein kiase C in human skeletal muscle insulin resistance and obesity[J]. Diabetes,2000,49(8):1353-1358.
  • 9[9]Sayeed MM. Alterations in calcium signaling and cellular responses in septic injury[J].New Horiz,1996,4(1):72-86.
  • 10[10]Li Z,Joyal,Sacks DB,et al.Binding of IRS proteins to calmodulin is enhanced in insulin resistance[J].Biochemistry,2000,39(17):5089-5096.

共引文献18

同被引文献488

引证文献41

二级引证文献319

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部